No Detail Found!

Computational Prediction of Olea europaea Compounds as nhibitor of Main-Peptidase of SARS-CoV2

Author(s)
Rashid Saif Institute of Biotechnology, Gulab Devi Educational Complex, Lahore, Pakistan; Decode Genomics, Punjab University Employees Housing Scheme (II), Lahore, Pakistan
Ghafran Ali Institute of Biotechnology, Gulab Devi Educational Complex, Lahore, Pakistan
Kanza Ashfaq Institute of Biotechnology, Gulab Devi Educational Complex, Lahore, Pakistan
Saeeda Zia Department of Sciences and Humanities, National University of Computer and Emerging Sciences, Lahore, Pakistan
Abdul Rasheed Qureshi Department-Pulmonology, Gulab Devi Chest Hospital, Lahore, Pakistan
Abstract
Background: In December 2019, Severe Acute Respiratory Syndrome Novel Coronavirus 2 (SARS-nCOV2) was identified as potential causative agent for COVID-19 in the Wuhan City of China. This disease spread ackground: In December 2019, Severe Acute Respiratory Syndrome Novel Coronavirus 2 (SARS-nCOV2) around the whole globe, thus WHO declared it as a pandemic by March 11, 2020. Due to rapid mutation rate, lack of specific genomic knowledge and treatment modalities against this RNA based virus, world scientific community urges to work for vaccine production, treatments options and alternative remedies including eastern herbs as potential anti-viral agents. Methods: Olea europaea (Olive) was found highly beneficial on the basis of its previous therapeutic applications. So, in the current study, its five different compounds (Catechin, Cynaroside, Elenolic Acid, Hydroxytyrosol, and Oleuropein) were chosen according to Lipinski physiochemical parameters, which were compared with already clinically used five anti-viral drugs (Ribavirin, Niclosamide, Nelfinavir, S-Nitroso-N-acetyl penicillamine, Chloroquine) against the Main-Peptidase (PDB ID:2GTB) of SARS-nCoV2 using Molecular Operating Environment (MOE) software. Results: Among the chosen compounds of Olea europaea which were docked on the active site of MainPeptidase, Oleuropein provide the best minimum binding energy of -8.3201kcal/mol followed by Cynaroside with -7.2121kcal/mol. These two energy complexes are considered to have better drug potential in this initial studies as compare to the already commercially used drug agents e.g. Chloroquine, Ribavirin, Niclosamide and SNitroso-N-acetyl Penicillamine having binding energy of -6.7168, -5.8171, -6.3361 and -5.4219kcal/mol respectively. Other three agents from olive were also docked to compare the binding energy of aforementioned clinically used drugs. Conclusion: Oleuropein and Cynaroside are considered to be the most compelling compounds as a drug agent against coronavirus2 infection. Further, molecular dynamic simulations and in-vivo investigations are needed to endorse the current findings of these compounds as potential drugs.
Publication Details
Page(s) 133-136
DOI DOI not available
Published Journal: Advancements in life sciences, Volume: 8, Issue: 2, Year: 2021

Request the full text from PASTIC

Keywords
molecular docking, SARSnCoV2, MOE software, 2 GTB
0

Citations

0

Downloads

62

Views